Data month 2026-08
Iambic Therapeuticsiambic.aiUsing AI to predict protein structures and generate molecular designs
According to AlphaMoat, in 2026-08 Iambic Therapeutics (iambic.ai) received 16,888 monthly visits (+64.8% MoM) — ranked #8,185 of 17,407 AI websites with traffic data, and #1,134 of 3,173 in Industry Services; its largest market is United States (74.6% of visits).
Monthly Visits · 2026-08
16.9K+64.8%
Overall Rank (17,407)
#8,185
Industry Services Rank (3,173)
#1,134
Top Market
United States74.6%
What is Iambic Therapeutics
Product Overview
Iambic Therapeutics (formerly Entos) uses artificial intelligence to predict protein and ligand structures and generate molecular designs to discover new drugs.
Key Features2 items
- 01The platform combines structural biology with generative models to accelerate the ideation and screening of candidate molecules
- 02R&D teams can thereby explore a broader chemical space and shorten early drug-discovery cycles
12-Month Traffic Trend
Hover for monthly values
Latest 16.9KMoM+64.8%
2026-06
17.6K
—
2026-07
10.2K
-41.7%
2026-08
16.9K
+64.8%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
12,60574.6%
Canada
1,6129.5%
UK
1,4978.9%
India
1,1747.0%
Popular in Industry Services
Click for details, or "+ Compare" to compare with Iambic Therapeutics
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.